Literature DB >> 12801803

Regulation of dendritic cell function by microbial stimuli.

C Reis e Sousa1, S D Diebold, A D Edwards, N Rogers, O Schulz, R Spörri.   

Abstract

Dendritic cells (DC) initiate T cell responses and produce cytokines and other molecules that can regulate the class adaptive immunity. It is increasingly clear that DC in vivo are in a "resting" state and require exogenous signals to transit into an "effector" state in which they can prime T cells. Much of this DC activation process appears to be regulated by infection. Exposure of murine DC to certain pathogens or their products triggers DC migration to T cell areas of secondary lymphoid tissues, improves MHC presentation and increases DC co-stimulatory potential. Pathogen recognition can also initiate cytokine production and/or condition DC to produce cytokines in response to subsequent T cell feedback signals delivered via CD40 and similar receptors. Recognition of pathogens by DC is largely dependent on Toll-like receptors (TLRs). Interestingly, mouse splenic CD8alpha+ and CDalpha-CD4- DC have the ability to produce either IL-12 p70 or IL-10 depending on the nature of the pathogen encountered. In contrast, CD4+ DC seem incapable of producing IL-12 p70. Thus, the nature of the pathogen can dictate the type of cytokine that is made by some DC subsets, allowing them to prime distinct types of immune responses. Overall, DC display significant plasticity in their ability to respond to infection and direct adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801803     DOI: 10.1016/s0369-8114(03)00099-3

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  10 in total

1.  Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.

Authors:  Ryan M Kelly; Jianmin Chen; Lauren E Yauch; Stuart M Levitz
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 2.  What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis.

Authors:  Marcus Maurer; Blaise Dondji; Esther von Stebut
Journal:  Med Microbiol Immunol       Date:  2009-04-25       Impact factor: 3.402

Review 3.  The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.

Authors:  Morgan E Wallace; Mark J Smyth
Journal:  Springer Semin Immunopathol       Date:  2005-02-24

4.  Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.

Authors:  Esra Ozcan; Ingrid Rauter; Lilit Garibyan; Stacey R Dillon; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2011-07-07       Impact factor: 10.793

5.  Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.

Authors:  Esra Ozcan; Lilit Garibyan; John Jhe-Yun Lee; Richard J Bram; Kong-Peng Lam; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2009-05-08       Impact factor: 10.793

6.  CD1d activation and blockade: a new antitumor strategy.

Authors:  Michele W L Teng; Simon Yue; Janelle Sharkey; Mark A Exley; Mark J Smyth
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

7.  Salmonella enterica serovar Typhi plasmid impairs dendritic cell responses to infection.

Authors:  Li Wei; Shuyan Wu; Yuanyuan Li; Yuanyuan Chu; Rui Huang
Journal:  Curr Microbiol       Date:  2012-05-09       Impact factor: 2.188

8.  Inhalation injury in severely burned children does not augment the systemic inflammatory response.

Authors:  Celeste C Finnerty; David N Herndon; Marc G Jeschke
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  Trichinella spiralis paramyosin activates mouse bone marrow-derived dendritic cells and induces regulatory T cells.

Authors:  Kai Guo; Ximeng Sun; Yuan Gu; Zixia Wang; Jingjing Huang; Xinping Zhu
Journal:  Parasit Vectors       Date:  2016-11-04       Impact factor: 3.876

10.  Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity.

Authors:  Stefan F Martin; Jan C Dudda; Eva Bachtanian; Annalisa Lembo; Stefanie Liller; Christoph Dürr; Markus M Heimesaat; Stefan Bereswill; György Fejer; Ralitsa Vassileva; Thilo Jakob; Nikolaus Freudenberg; Christian C Termeer; Caroline Johner; Chris Galanos; Marina A Freudenberg
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.